It was reported that, a right thoracic drainage tube was placed on the patient, two days later the skin at the edge of one (1) iv3000 1 hand 10x12cm ctn 50 was found red.The dressing was replaced, and four days later, blisters were scattered around.The next day, the blisters had ruptured, that same day, patient underwent chest ct examination and the pleural effusion was reduced.The thoracic drainage and the film were removed according to the doctor's advice.Lyophilized recombinant human acidic fibroblast growth factor for external use was applied.Current patient's health status is unknown.
|
Section h3, h6: it was reported that, a right thoracic drainage tube was placed on the patient, two days later the skin at the edge of one (1) iv3000 1 hand 10x12cm ctn 50 was found red.The dressing was replaced, and four days later, blisters were scattered around.The next day, the blisters had ruptured, that same day, patient underwent chest ct examination and the pleural effusion was reduced.The thoracic drainage and the film were removed according to the doctor's advice.Lyophilized recombinant human acidic fibroblast growth factor for external use was applied.Current patient's health status is unknown.The device was not returned for analysis.We have therefore not been able to confirm a relationship between the event and the device, or identify a definitive root cause.A lot number for the device was not provided, therefore it was not possible to carry out a device history review.A complaint history review (chr) revealed a small number of similar instances in the last 12 months.There is nothing to indicate this is outside of acceptable rates of occurrence.A clinical/medical evaluation was conducted, and was unable to rule out a procedural variance as a contributing factor to the reported event, rather than the device itself not functioning correctly.The iv3000 standard should be used on iv sites only.If a film dressing is required for open wounds such as pressure sores, burns, or donor sites, opsite flexigrid should be used.The health status of the patient is unknown, therefore the impact to the patient beyond that which has already reported cannot be confirmed nor concluded.Consequently, no further clinical/medical assessment is warranted at this time.A risk management review was conducted and which mitigated the reported issue with no further action or updates required.The ifu has been reviewed and contains comprehensive instructions on the safe operation and use of the device, including specific direction that the product should only be used on iv sites and precautionary advice where sensitive/fragile skin is an issue.A review of records held concluded that there are no prior escalated actions related to this product and the reported event.The probable root cause for this complaint is that the patient's skin was sensitive to one or more of the components of the dressing, leading to the reaction as reported in the complaint detail.Existing skin condition(s) might also be a contributing factor, as could the choice of dressing for the intended purpose.The users of the reported product are advised to consult the relevant ifu, to prevent future occurrences of the reported issue.Investigations into this matter are now complete.No further actions by smith & nephew are deemed necessary at this stage.However, we will continue to monitor for any adverse trends relating to this product range.Smith & nephew acknowledge customer concern and are continually investigating ways to develop and improve our products.H6: health effect - impact code.
|